Dysregulated Wnt and NFAT signaling in a Parkinson's disease LRRK2 G2019S knock-in model
Andrea Wetzel, Si Hang LeiiD, Tiansheng LiuiD, Michael P. HughesiD, Yunan PengiD, Tristan R. McKayiD, Simon N. WaddingtoniD, Simone GrannòiD, Ahad A. RahimiD, Kirsten HarveyiD
Abstract
BackgroundParkinsons disease (PD) is a progressive late-onset neurodegenerative disease leading to physical and cognitive decline. Mutations of leucine-rich repeat kinase 2 (LRRK2) are the most common genetic cause of PD. LRRK2 is a complex scaffolding protein with known regulatory roles in multiple molecular pathways. Two prominent examples of LRRK2-modulated pathways are Wingless/Int (Wnt) and nuclear factor of activated T-cells (NFAT) signaling. Both are well described key regulators of immune and nervous system development as well as maturation. The aim of this study was to establish the physiological and pathogenic role of LRRK2 in Wnt and NFAT signaling in the brain, as well as the potential contribution of the non-canonical Wnt/Calcium pathway. MethodsIn vivo cerebral Wnt and NFATc1 signaling activity was quantified in LRRK2 G2019S mutant knock-in (KI) and LRRK2 knockout (KO) male and female mice with repeated measures over 28 weeks, employing lentiviral luciferase biosensors, and analyzed using a mixed-effect model. To establish spatial resolution, we investigated tissues, and primary neuronal cell cultures from different brain regions combining luciferase signaling activity, immunohistochemistry, qPCR and western blot assays. Results were analyzed by unpaired t-test with Welchs correction or 2-way ANOVA with post hoc corrections. ResultsIn vivo Wnt signaling activity in LRRK2 KO and LRRK2 G2019S KI mice was increased significantly [~]3-fold, with a more pronounced effect in males ([~]4-fold) than females ([~]2-fold). NFATc1 signaling was reduced [~]0.5-fold in LRRK2 G2019S KI mice. Brain tissue analysis showed region-specific expression changes in Wnt and NFAT signaling components. These effects were predominantly observed at the protein level in the striatum and cerebral cortex of LRRK2 KI mice. Primary neuronal cell culture analysis showed significant genotype-dependent alterations in Wnt and NFATc1 signaling under basal and stimulated conditions. Wnt and NFATc1 signaling was primarily dysregulated in cortical and hippocampal neurons respectively. ConclusionsOur study further built on knowledge of LRRK2 as a Wnt and NFAT signaling protein. We identified complex changes in neuronal models of LRRK2 PD, suggesting a role for mutant LRRK2 in the dysregulation of NFAT, and canonical and non-canonical Wnt signaling.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 19
- FWCI
- 5.06
- Field percentile
- top 4%
- Organism
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Dopaminergic Neurodegeneration Induced by Parkinson's Disease-Linked G2019S LRRK2 is Dependent on Kinase and GTPase Activity
An Phu Tran Nguyen, Elpida Tsika, … Darren J. Moore·Proceedings of the National Academy of SciencesPeer-reviewed·Jul 6, 2020
- Neuronal hyperactivity in a LRRK2-G2019S cellular model of Parkinson's Disease
Edinson Lucumi Moreno, Siham Hachi, … Ronan M. T. Fleming·bioRxiv·Jun 23, 2021
- Regulation between LRRK2 and PP2A signaling in cellular models of Parkinsons disease
Panagiotis S. Athanasopoulos, Anna Memou, … Arjan Kortholt·Biochemical JournalPeer-reviewed·May 14, 2026
- LRRK2 kinase inhibition reverses G2019S mutation-dependent effects on tau pathology spread
Noah Lubben, Julia K. Brynildsen, … Michael X. Henderson·Translational NeurodegenerationPeer-reviewed·Mar 4, 2024
- LRRK2 regulates synaptic function through modulation of actin cytoskeletal dynamics
Giulia Tombesi, Shiva N. Kompella, … Elisa Greggio·eLifePeer-reviewed·Aug 6, 2026
- Multiple pathways of LRRK2-G2019S / Rab10 interaction in dopaminergic neurons
Alison Fellgett, C. Adam Middleton, … Christopher J. H. Elliott·Journal of Parkinson s DiseasePeer-reviewed·Jul 7, 2021